Entero Therapeutics Statistics
Total Valuation
ENTO has a market cap or net worth of $2.37 million. The enterprise value is $2.12 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENTO has 4.75 million shares outstanding. The number of shares has increased by 1,324.34% in one year.
| Current Share Class | 4.75M |
| Shares Outstanding | 4.75M |
| Shares Change (YoY) | +1,324.34% |
| Shares Change (QoQ) | +98.41% |
| Owned by Insiders (%) | 1.45% |
| Owned by Institutions (%) | 1.61% |
| Float | 4.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.34, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.34 |
| Quick Ratio | 0.02 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,978.77 |
Financial Efficiency
Return on equity (ROE) is -21.60% and return on invested capital (ROIC) is -31.39%.
| Return on Equity (ROE) | -21.60% |
| Return on Assets (ROA) | -25.22% |
| Return on Invested Capital (ROIC) | -31.39% |
| Return on Capital Employed (ROCE) | -26.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.13M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.04% in the last 52 weeks. The beta is 1.00, so ENTO's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -89.04% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 44.20 |
| Average Volume (20 Days) | 118,432 |
Short Selling Information
The latest short interest is 142,747, so 3.00% of the outstanding shares have been sold short.
| Short Interest | 142,747 |
| Short Previous Month | 96,042 |
| Short % of Shares Out | 3.00% |
| Short % of Float | 3.05% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.51M |
| Pretax Income | n/a |
| Net Income | -10.15M |
| EBITDA | -18.46M |
| EBIT | -18.51M |
| Earnings Per Share (EPS) | -$4.14 |
Full Income StatementBalance Sheet
The company has $366,788 in cash and $159,667 in debt, giving a net cash position of $207,121 or $0.04 per share.
| Cash & Cash Equivalents | 366,788 |
| Total Debt | 159,667 |
| Net Cash | 207,121 |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 70.05M |
| Book Value Per Share | 1.76 |
| Working Capital | 68.15M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.49M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.49M |
| FCF Per Share | -$2.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |